Cardiovascular Diabetology | Most Viewed

Submit a manuscript Register Contact us Follow
BioMed Central Support

Explore journal

Advertisement

Articles

Display/download options Articles per page: 25 | 50 | 100

Display options

Editor's summary Citation

Download options

Send
To

	All
	1. 48152 Accesses	Review Vascular ossification – calcification in metabolic syndrome, type 2 diabetes mellitus, chronic kidney disease, and calciphylaxis – calcific uremic arteriolopathy: the emerging role of sodium thiosulfate Melvin R Hayden, Suresh C Tyagi, Lisa Kolb, James R Sowers, Ramesh Khanna Cardiovascular Diabetology 2005, 4:4 (18 March 2005) Abstract \| Full text \| PDF \| PubMed \| Cited on BioMed Central
	2. 42507 Accesses	Review How hyperglycemia promotes atherosclerosis: molecular mechanisms Doron Aronson, Elliot J Rayfield Cardiovascular Diabetology 2002, 1:1 (8 April 2002) Abstract \| Full text \| PDF \| PubMed \| Cited on BioMed Central
	3. 40590 Accesses	Review Endothelial dysfunction: a comprehensive appraisal Ricardo J Esper, Roberto A Nordaby, Jorge O Vilariño, Antonio Paragano, José L Cacharrón, Rogelio A Machado Cardiovascular Diabetology 2006, 5:4 (23 February 2006) Abstract \| Full text \| PDF \| PubMed \| Cited on BioMed Central
	4. 33926 Accesses	Review Oxidative stress and the use of antioxidants in diabetes: Linking basic science to clinical practice Jeanette Johansen, Alex K Harris, David J Rychly, Adviye Ergul Cardiovascular Diabetology 2005, 4:5 (29 April 2005) Abstract \| Full text \| PDF \| PubMed \| Cited on BioMed Central \| 1 comment
	5. 30838 Accesses	Review Influence of diabetes mellitus on heart failure risk and outcome Christophe Bauters, Nicolas Lamblin, Eugène P Mc Fadden, Eric Van Belle, Alain Millaire, Pascal de Groote Cardiovascular Diabetology 2003, 2:1 (8 January 2003) Abstract \| Full text \| PDF \| PubMed \| Cited on BioMed Central
	6. 30172 Accesses	Review Intimal redox stress: Accelerated atherosclerosis in metabolic syndrome and type 2 diabetes mellitus. Atheroscleropathy Melvin R Hayden, Suresh C Tyagi Cardiovascular Diabetology 2002, 1:3 (27 September 2002) Abstract \| Full text \| PDF \| PubMed \| Cited on BioMed Central
	7. 28797 Accesses	Review Metabolic syndrome and type 2 diabetes mellitus: focus on peroxisome proliferator activated receptors (PPAR) Alexander Tenenbaum, Enrique Z Fisman, Michael Motro Cardiovascular Diabetology 2003, 2:4 (23 March 2003) Abstract \| Full text \| PDF \| PubMed \| Cited on BioMed Central
	8. 25504 Accesses	Original investigation Trimetazidine improves left ventricular function in diabetic patients with coronary artery disease: a double-blind placebo-controlled study Giuseppe MC Rosano, Cristiana Vitale, Barbara Sposato, Giuseppe Mercuro, Massimo Fini Cardiovascular Diabetology 2003, 2:16 (28 November 2003) Abstract \| Full text \| PDF \| PubMed
	9. 23108 Accesses	Original investigation Beneficial effects of a Paleolithic diet on cardiovascular risk factors in type 2 diabetes: a randomized cross-over pilot study Tommy Jönsson, Yvonne Granfeldt, Bo Ahrén, Ulla-Carin Branell, Gunvor Pålsson, Anita Hansson, Margareta Söderström, Staffan Lindeberg Cardiovascular Diabetology 2009, 8:35 (16 July 2009) Abstract \| Full text \| PDF \| PubMed \| Cited on BioMed Central
	10. 20901 Accesses	Hypothesis Is type 2 diabetes mellitus a vascular disease (atheroscleropathy) with hyperglycemia a late manifestation? The role of NOS, NO, and redox stress. Melvin R Hayden, Suresh C Tyagi Cardiovascular Diabetology 2003, 2:2 (12 February 2003) Abstract \| Full text \| PDF \| PubMed \| Cited on BioMed Central
	11. 20881 Accesses	Original investigation Telmisartan/hydrochlorothiazide versus valsartan/hydrochlorothiazide in obese hypertensive patients with type 2 diabetes: the SMOOTH study Arya M Sharma, Jaime Davidson, Stephen Koval, Yves Lacourcière Cardiovascular Diabetology 2007, 6:28 (2 October 2007) Abstract \| Full text \| PDF \| PubMed \| Cited on BioMed Central
	12. 20833 Accesses	Original investigation Metabolic effect of telmisartan and losartan in hypertensive patients with metabolic syndrome Cristiana Vitale, Giuseppe Mercuro, Carlotta Castiglioni, Alessandra Cornoldi, Arianna Tulli, Massimo Fini, Maurizio Volterrani, Giuseppe MC Rosano Cardiovascular Diabetology 2005, 4:6 (15 May 2005) Abstract \| Full text \| PDF \| PubMed \| Cited on BioMed Central
	13. 20323 Accesses	Original investigation Comparison of rosuvastatin and atorvastatin for lipid lowering in patients with type 2 diabetes mellitus: results from the URANUS study Christian Berne, Annica Siewert-Delle, the URANUS study investigators Cardiovascular Diabetology 2005, 4:7 (3 June 2005) Abstract \| Full text \| PDF \| PubMed \| Cited on BioMed Central
	14. 18944 Accesses	Original investigation Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study: baseline characteristics and short-term effects of fenofibrate [ISRCTN64783481] The FIELD Study Investigators Cardiovascular Diabetology 2005, 4:13 (22 August 2005) Abstract \| Full text \| PDF \| PubMed \| Cited on BioMed Central
	15. 18140 Accesses	Case Report Isolated low high density lipoprotein-cholesterol (HDL-C): implications of global risk reduction. Case report and systematic scientific review Melvin R Hayden, Suresh C Tyagi Cardiovascular Diabetology 2005, 4:1 (4 January 2005) Abstract \| Full text \| PDF \| PubMed \| Cited on BioMed Central \| 1 comment
	16. 18135 Accesses	Original investigation Evaluation of the cost effectiveness of exenatide versus insulin glargine in patients with sub-optimally controlled Type 2 diabetes in the United Kingdom Anette Woehl, Mark Evans, Anthony P Tetlow, Philip McEwan Cardiovascular Diabetology 2008, 7:24 (11 August 2008) Abstract \| Full text \| PDF \| PubMed \| Cited on BioMed Central
	17. 17843 Accesses	Review Vasa vasorum in plaque angiogenesis, metabolic syndrome, type 2 diabetes mellitus, and atheroscleropathy: a malignant transformation Melvin R Hayden, Suresh C Tyagi Cardiovascular Diabetology 2004, 3:1 (4 February 2004) Abstract \| Full text \| PDF \| PubMed \| Cited on BioMed Central \| 1 comment
	18. 17248 Accesses	Review Atherogenic dyslipidemia in metabolic syndrome and type 2 diabetes: therapeutic options beyond statins Alexander Tenenbaum, Enrique Z Fisman, Michael Motro, Yehuda Adler Cardiovascular Diabetology 2006, 5:20 (26 September 2006) Abstract \| Full text \| PDF \| PubMed \| Cited on BioMed Central
	19. 16269 Accesses	Commentary Losartan and diabetic nephropathy: commentaries on the RENAAL study Enrique Z Fisman, Alexander Tenenbaum, Michael Motro Cardiovascular Diabetology 2002, 1:2 (8 April 2002) Abstract \| Full text \| PDF \| PubMed
	20. 15871 Accesses	Review The central role of vascular extracellular matrix and basement membrane remodeling in metabolic syndrome and type 2 diabetes: the matrix preloaded Melvin R Hayden, James R Sowers, Suresh C Tyagi Cardiovascular Diabetology 2005, 4:9 (28 June 2005) Abstract \| Full text \| PDF \| PubMed \| Cited on BioMed Central
	21. 15476 Accesses	Original investigation Brachial-ankle pulse wave velocity and symptomatic cerebral infarction in patients with type 2 diabetes: a cross-sectional study Osamu Ogawa, Tomio Onuma, Sayaka Kubo, Naomi Mitsuhashi, Chie Muramatsu, Ryuzo Kawamori Cardiovascular Diabetology 2003, 2:10 (28 August 2003) Abstract \| Full text \| PDF \| PubMed \| Cited on BioMed Central
	22. 14252 Accesses	Review Dual and pan-peroxisome proliferator-activated receptors (PPAR) co-agonism: the bezafibrate lessons Alexander Tenenbaum, Michael Motro, Enrique Z Fisman Cardiovascular Diabetology 2005, 4:14 (16 September 2005) Abstract \| Full text \| PDF \| PubMed \| Cited on BioMed Central \| 1 comment
	23. 13723 Accesses	Original investigation Target organ damage and cardiovascular complications in patients with hypertension and type 2 diabetes in Spain: a cross-sectional study Luis Cea-Calvo, Pedro Conthe, Pablo Gómez-Fernández, Fernando de Alvaro, Cristina Fernández-Pérez, RICARHD investigators Cardiovascular Diabetology 2006, 5:23 (3 November 2006) Abstract \| Full text \| PDF \| PubMed \| Cited on BioMed Central
	24. 12958 Accesses	Original investigation The need for a large-scale trial of fibrate therapy in diabetes: the rationale and design of the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study. [ISRCTN64783481] The FIELD Study Investigators Cardiovascular Diabetology 2004, 3:9 (1 December 2004) Abstract \| Full text \| PDF \| PubMed \| Cited on BioMed Central
	25. 12424 Accesses	Review Regular physical exercise training assists in preventing type 2 diabetes development: focus on its antioxidant and anti-inflammatory properties Edite Teixeira-Lemos, Sara Nunes, Frederico Teixeira, Flávio Reis Cardiovascular Diabetology 2011, 10:12 (28 January 2011) Abstract \| Full text \| PDF \| PubMed \| Cited on BioMed Central
	26. 12256 Accesses	Review Postprandial hyperglycemia as an etiological factor in vascular failure Koichi Node, Teruo Inoue Cardiovascular Diabetology 2009, 8:23 (29 April 2009) Abstract \| Full text \| PDF \| PubMed \| Cited on BioMed Central \| 1 comment
	27. 11835 Accesses	Methodology Elevated serum triglycerides is the strongest single indicator for the presence of metabolic syndrome in patients with type 2 diabetes Maria Kompoti, Anargiros Mariolis, Alevizos Alevizos, Ioannis Kyriazis, Ioannis Protopsaltis, Eleni Dimou, Ioannis Lentzas, Dimitrios Levisianou, Afroditi Gova, Andreas Melidonis Cardiovascular Diabetology 2006, 5:21 (4 October 2006) Abstract \| Full text \| PDF \| PubMed \| Cited on BioMed Central
	28. 11638 Accesses	Review Blood pressure reduction, persistence and costs in the evaluation of antihypertensive drug treatment – a review Peter Bramlage, Joerg Hasford Cardiovascular Diabetology 2009, 8:18 (27 March 2009) Abstract \| Full text \| PDF \| PubMed \| Cited on BioMed Central
	29. 11112 Accesses	Original investigation Cardiovascular adaptations to exercise training in postmenopausal women with type 2 diabetes mellitus Jonathan McGavock, Sandra Mandic, Richard Lewanczuk, Matthew Koller, Isabelle Muhll, Arthur Quinney, Dylan Taylor, Robert Welsh, Mark Haykowsky Cardiovascular Diabetology 2004, 3:3 (15 March 2004) Abstract \| Full text \| PDF \| PubMed
	30. 11006 Accesses	Original investigation Irbesartan for the treatment of hypertension in patients with the metabolic syndrome: A sub analysis of the Treat to Target post authorization survey. Prospective observational, two armed study in 14,200 patients Ulrich Kintscher, Peter Bramlage, W Dieter Paar, Martin Thoenes, Thomas Unger Cardiovascular Diabetology 2007, 6:12 (3 April 2007) Abstract \| Full text \| PDF \| PubMed \| Cited on BioMed Central
	31. 10907 Accesses	Original investigation Human epicardial adipose tissue expresses a pathogenic profile of adipocytokines in patients with cardiovascular disease Adam R Baker, Nancy F da Silva, David W Quinn, Alison L Harte, Domenico Pagano, Robert S Bonser, Sudhesh Kumar, Philip G McTernan Cardiovascular Diabetology 2006, 5:1 (13 January 2006) Abstract \| Full text \| PDF \| PubMed \| Cited on BioMed Central
	32. 10842 Accesses	Original investigation Low serum amylase in association with metabolic syndrome and diabetes: A community-based study Kei Nakajima, Tohru Nemoto, Toshitaka Muneyuki, Masafumi Kakei, Hiroshi Fuchigami, Hiromi Munakata Cardiovascular Diabetology 2011, 10:34 (17 April 2011) Abstract \| Full text \| PDF \| PubMed \| Cited on BioMed Central \| 1 comment
	33. 10841 Accesses	Original investigation Ciprofibrate therapy in patients with hypertriglyceridemia and low high density lipoprotein (HDL)-cholesterol: greater reduction of non-HDL cholesterol in subjects with excess body weight (The CIPROAMLAT study) Carlos A Aguilar-Salinas, Andréia Assis-Luores-Vale, Benjamín Stockins, Hector Rengifo, José Filho, Abrahão Neto, Lísia Rabelo, Kerginaldo Torres, José Oliveira, Carlos Machado, Eliana Reyes, Victor Saavedra, Fernando Florenzano, Ma Hernández, Sergio Jiménez, Erika Ramírez, Cuauhtémoc Vazquez, Saul Salinas, Ismael Hernández, Octavio Medel, Ricardo Moreno, Paula Lugo, Ricardo Alvarado, Roopa Mehta, Victor Gutierrez, Francisco J Gómez Pérez Cardiovascular Diabetology 2004, 3:8 (23 July 2004) Abstract \| Full text \| PDF \| PubMed \| 1 comment
	34. 10630 Accesses	Review Renal protection in diabetes: lessons from ONTARGET^® Eberhard Ritz, Roland E Schmieder, Carol A Pollock Cardiovascular Diabetology 2010, 9:60 (1 October 2010) Abstract \| Full text \| PDF \| PubMed \| Cited on BioMed Central
	35. 10564 Accesses	Review The clinical relevance of assessing advanced glycation endproducts accumulation in diabetes Robbert Meerwaldt, Thera Links, Clark Zeebregts, Rene Tio, Jan-Luuk Hillebrands, Andries Smit Cardiovascular Diabetology 2008, 7:29 (7 October 2008) Abstract \| Full text \| PDF \| PubMed \| Cited on BioMed Central
	36. 10545 Accesses	Review A cardiologic approach to non-insulin antidiabetic pharmacotherapy in patients with heart disease Enrique Z Fisman, Alexander Tenenbaum Cardiovascular Diabetology 2009, 8:38 (20 July 2009) Abstract \| Full text \| PDF \| PubMed \| Cited on BioMed Central \| 1 comment
	37. 10448 Accesses	Original investigation Comparison of vildagliptin twice daily vs. sitagliptin once daily using continuous glucose monitoring (CGM): Crossover pilot study (J-VICTORIA study) Masaya Sakamoto, Rimei Nishimura, Taiga Irako, Daisuke Tsujino, Kiyotaka Ando, Kazunori Utsunomiya Cardiovascular Diabetology 2012, 11:92 (6 August 2012) Abstract \| Full text \| PDF \| PubMed \| Cited on BioMed Central
	38. 10352 Accesses	Review Therapies for type 2 diabetes: lowering HbA1c and associated cardiovascular risk factors L Romayne Kurukulasuriya, James R Sowers Cardiovascular Diabetology 2010, 9:45 (30 August 2010) Abstract \| Full text \| PDF \| PubMed \| Cited on BioMed Central \| 1 comment
	39. 10350 Accesses	Original investigation Cardiovascular safety with linagliptin in patients with type 2 diabetes mellitus: a pre-specified, prospective, and adjudicated meta-analysis of a phase 3 programme Odd Johansen, Dietmar Neubacher, Maximilian von Eynatten, Sanjay Patel, Hans-Juergen Woerle Cardiovascular Diabetology 2012, 11:3 (10 January 2012) Abstract \| Full text \| PDF \| PubMed \| Cited on BioMed Central
	40. 10323 Accesses	Original investigation Increased prevalence of left ventricular hypertrophy in hypertensive women with type 2 diabetes mellitus Alexander Tenenbaum, Enrique Z Fisman, Ehud Schwammenthal, Yehuda Adler, Michal Benderly, Michael Motro, Joseph Shemesh Cardiovascular Diabetology 2003, 2:14 (23 November 2003) Abstract \| Full text \| PDF \| PubMed
	41. 10226 Accesses	Review What is a preferred angiotensin II receptor blocker-based combination therapy for blood pressure control in hypertensive patients with diabetic and non-diabetic renal impairment? Samir G Mallat Cardiovascular Diabetology 2012, 11:32 (10 April 2012) Abstract \| Full text \| PDF \| PubMed \| Cited on BioMed Central
	42. 10029 Accesses	Editorial Which is the best lipid-modifying strategy in metabolic syndrome and diabetes: fibrates, statins or both? Alexander Tenenbaum, Enrique Z Fisman Cardiovascular Diabetology 2004, 3:10 (1 December 2004) Abstract \| Full text \| PDF \| PubMed \| Cited on BioMed Central
	43. 9850 Accesses	Original investigation Gender differences in factors influencing insulin resistance in elderly hyperlipemic non-diabetic subjects Radka Lichnovská, Simona Gwozdziewiczová, Jirí Hrebícek Cardiovascular Diabetology 2002, 1:4 (14 October 2002) Abstract \| Full text \| PDF \| PubMed \| Cited on BioMed Central
	44. 9718 Accesses	Original investigation Silent coronary artery disease in type 2 diabetes mellitus: the role of Lipoprotein(a), homocysteine and apo(a) polymorphism Carmine Gazzaruso, Adriana Garzaniti, Stefano Giordanetti, Colomba Falcone, Pietro Fratino Cardiovascular Diabetology 2002, 1:5 (22 November 2002) Abstract \| Full text \| PDF \| PubMed \| Cited on BioMed Central
	45. 9478 Accesses	Original investigation Silent myocardial infarction in women with impaired glucose tolerance: The Northern Sweden MONICA study Dan Lundblad, Mats Eliasson Cardiovascular Diabetology 2003, 2:9 (21 August 2003) Abstract \| Full text \| PDF \| PubMed \| Cited on BioMed Central
	46. 9217 Accesses	Original investigation Dyslipidemia in primary care – prevalence, recognition, treatment and control: data from the German Metabolic and Cardiovascular Risk Project (GEMCAS) Elisabeth Steinhagen-Thiessen, Peter Bramlage, Christian Lösch, Hans Hauner, Heribert Schunkert, Anja Vogt, Jürgen Wasem, Karl-Heinz Jöckel, Susanne Moebus Cardiovascular Diabetology 2008, 7:31 (15 October 2008) Abstract \| Full text \| PDF \| PubMed \| Cited on BioMed Central
	47. 9116 Accesses	Original investigation Angiotensin II receptor blockers decreased blood glucose levels: a longitudinal survey using data from electronic medical records Noboru Kitamura, Yasuo Takahashi, Shuukoh Yamadate, Satoshi Asai Cardiovascular Diabetology 2007, 6:26 (29 September 2007) Abstract \| Full text \| PDF \| PubMed \| Cited on BioMed Central
	48. 9007 Accesses	Original investigation A randomized controlled trial on the efficacy of carbohydrate-reduced or fat-reduced diets in patients attending a telemedically guided weight loss program Sabine Frisch, Armin Zittermann, Heiner K Berthold, Christian Götting, Joachim Kuhn, Knut Kleesiek, Peter Stehle, Heinrich Körtke Cardiovascular Diabetology 2009, 8:36 (18 July 2009) Abstract \| Full text \| PDF \| PubMed \| Cited on BioMed Central
	49. 9000 Accesses	Original investigation Distinct effects of glucose and glucosamine on vascular endothelial and smooth muscle cells: Evidence for a protective role for glucosamine in atherosclerosis Wenlan Duan, Latha Paka, Sivaram Pillarisetti Cardiovascular Diabetology 2005, 4:16 (5 October 2005) Abstract \| Full text \| PDF \| PubMed
	50. 8910 Accesses	Original investigation Differential effects of fenofibrate versus atorvastatin on the concentrations of E-selectin and vascular cellular adhesion molecule-1 in patients with type 2 diabetes mellitus and mixed hyperlipoproteinemia: a randomized cross-over trial Klaus Empen, Robert JA Frost, H Geiss, Carsten Otto, Klaus G Parhofer Cardiovascular Diabetology 2003, 2:17 (8 December 2003) Abstract \| Full text \| PDF \| PubMed